FDA paves way for Pfizer Covid-19 vaccinations in young kids

The Food and Drug Administration on Friday paved the way for children ages 5 to 11 to get Pfizer’s Covid-19 vaccine. The FDA cleared kid-size doses — just a third of the amount given to teens and adults — for emergency use, and up to 28 million more American children could be eligible for vaccinations as early as next week.